Navigation Links
Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics

ophos. In vitro, TRO19622 promotes motor neuron survival in the absence of trophic support in a dose-dependent manner. In preclinical models in vivo, TRO19622 rescues motor neurons from axotomy-induced cell death in neonates and promotes nerve regeneration following sciatic nerve crush. Furthermore, in the SOD1G93A model of familial ALS, TRO19622 treatment improves motor performance, delays the onset of the clinical disease, and extends survival.

TRO19622 binds directly to two components of the mitochondrial permeability transition pore: the voltage-dependent anion channel (VDAC) and the translocator protein (or peripheral benzodiazepine receptor), suggesting a potential mechanism for its neuroprotective activity.

TRO19622 has successfully completed Phase I/Ib studies in both healthy volunteers and ALS patients demonstrating the product is well tolerated, has an excellent safety profile and that once-a-day dosing achieves the predicted exposure level required for efficacy, based on preclinical models. These data support the further clinical evaluation of TRO19622 as a potential treatment for ALS.

"Trophos is proud to have this body of work accepted for publication in a well recognized journal such as JPET," said Rebecca Pruss, CSO at Trophos. "Given the significant unmet medical need in ALS, it is tremendously encouraging that TRO19622 promotes the survival of motor neurons in this extensive battery of preclinical models. These studies, along with the excellent clinical safety profile of TRO19622, provide the basis upon which Trophos plans to initiate a pivotal Phase II/III trial to establish the clinical efficacy of TRO19622 in ALS patients."

Pruss added: "Moreover, we are particularly excited that there is increasing preclinical evidence that the mitochondria-mediated mechanism of action of TRO19622, and other compounds in this class, will have huge commercial potential in other chronic neurological disorders, such as neuropathic pain,
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Arrowhead Subsidiary, Insert, Publishes Interim Phase I Data from Human Clinical Trials for New Cancer Drug
2. New England Journal of Medicine Publishes New Data on Gardasil, Mercks Cervical Cancer Vaccine
3. The Lancet Publishes PREVAIL Study Results Showing Lovenox Superiority Over Unfractionated Heparin for Reducing the Risk of Venous ThromboEmbolism in Patients With Acute Ischemic Stroke
4. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
5. Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate
6. Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate
7. Medical Journal Publishes First Large-Scale Survey Revealing Experiences of IPF Patients
8. Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on Targeted, Systemic Delivery of siRNA
9. Calando Pharmaceuticals Publishes the First Non-Human Primate Study on Targeted, Systemic Delivery of siRNA in National Academy of Sciences Journal
10. JACC Publishes Long-Term Safety and Tolerability Data from Ranolazine Open Label Experience (ROLE) Program
11. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
Post Your Comments:
(Date:7/25/2014)... , July 25, 2014 /PRNewswire-iReach/ -- "Australia Capsule ... data on the Australia Capsule Endoscopy Systems market. The ... (in units) and average prices (in US dollars) within ... , Capsule Endoscopes , Capsule ... The report also provides company shares and ...
(Date:7/25/2014)... MISSION, Kan. , July 25, 2014 /PRNewswire-iReach/ ... , and TCGRx, of Powers Lake, ... exclusive partners in a distribution and co-marketing agreement ... to retail pharmacies throughout the United ... of robotics-based pharmacy management and workflow systems to ...
(Date:7/25/2014)... , July 25, 2014 GrowBLOX Sciences, Inc. (OTCQB: ... Memorandum of Understanding ("MOU") with LaurelCo, LLC, an ... acquisition of both cultivation and dispensary medical marijuana licenses in ... the MOU, GBLX will acquire a 20% equity interest in ... GrowBLOX TM growing chambers, as well as all technology ...
Breaking Medicine Technology:Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 3Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 4Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 5ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 2GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 3
... ACCESS PHARMACEUTICALS, INC.,(OTC Bulletin Board: ACCP) announced ... performed by Access collaborators at two,prominent institutes ... the joint,symposium of the American Association for ... European Organization for Research and Treatment,of Cancer ...
... Cells has Potential to Yield High ... and Therapeutic Products, ST. LOUIS and RICHMOND, Calif., Oct. ... Inc.,(Nasdaq: SGMO ) announced today the publication of data ... human stem,cells. This work represents a significant advance in the ...
Cached Medicine Technology:Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC 'Molecular Targets and Cancer Therapeutics' Conference 2Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC 'Molecular Targets and Cancer Therapeutics' Conference 3Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells 2Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells 3Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells 4Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells 5
(Date:7/26/2014)... Columbus, OH (PRWEB) July 26, 2014 Another ... subsidiary, DePuy Orthopedics, Inc., has been filed by Wright & ... been filed on behalf of an Erie County, Ohio ... in his left hip and groin since receiving his Pinnacle ... the Ohio man will be forced to undergo a complex ...
(Date:7/26/2014)... Seattle, Wa (PRWEB) July 26, 2014 ... recently updated by Vkool.com, this is a comprehensive guide ... eliminate unwanted tattoos . This book also teaches ... to imitate common medical procedures in their own home ... review that "Get Rid Tattoo Naturally" book includes step-by-step ...
(Date:7/25/2014)... PersonalInjurySolicitorsIreland, a legal claims company ... who have suffered from a variety of injuries, ... new company, and a website, http://www.PersonalInjurySolicitorsIreland.com . ... explained, http://www.personalinjurysolicitorsireland.com/personal-injury-claims , the law firm specialises ... company is always on the client, and everyone ...
(Date:7/25/2014)... 26, 2014 According to a ... by Product (vibration monitoring, thermography, ultrasound emission, lubricating ... Component, Application and Geography - Global Forecast to ... health monitoring market is expected to reach $2.50 ... 2020. , Browse 117 market data Tables and ...
(Date:7/25/2014)... As reported by the New Orleans Advocate in ... (7/3), the state of Louisiana has recently seen a large ... cocaine. Officials believe the increase is due to a misconception ... marijuana. However, both doctors and police confirm that that belief ... call it “poison,” doctors have acknowledged that the Louisiana Poison ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 5Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 2Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 3Health News:PersonalInjurySolicitorsIreland.com Announces the Launch of their New Company and Website 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Louisiana Recognizes Dangers of Synthetic Marijuana 2
... Nearly half of women treated for breast cancer did ... years are roughly the same whether they undergo mastectomy or ... be aware of this important factor of their treatment decision, ... Cancer Center. , Minority women were also less likely to ...
... new products introduced at the AHRMM08 Annual Conference & Exhibition, ... for purchase on limited release. , ... ... the company who pioneered web-based http://www.vendorclear.com/ [vendor ...
... July 30 Wounded Warrior Project,(WWP), a ... warriors,today announced that Michael Ward, chairman and ... wife Terry have personally contributed $1 million,toward ... donation is to support WWP,s new initiative ...
... strong, 85.6 million U.S., adults have doubted their opinion or ... information ... Hispanics most likely to rely on friends and family, NEW ... say they have doubted a medical professional,s,opinion or diagnosis because it conflicted ...
... (NYSE: ACS ) today announced a $4 million ... of New Orleans Emergency,Medical Services (EMS) agency., Under ... all New,Orleans, ambulances with the state-of-the-art FIREHOUSE (FH) Mobile ... patient data in,real-time, whether in the field at a ...
... 30 In conjunction,with DURECT Corporation,s (Nasdaq: ... you are invited to listen to the conference ... on Wednesday, August 6, 2008,at 9:00 a.m. EDT ... A live audio webcast of the presentation ...
Cached Medicine News:Health News:Minorities less likely to know about breast cancer treatment options 2Health News:Minorities less likely to know about breast cancer treatment options 3Health News:VendorClear™ Announces Limited Release of New Products for Healthcare Facilities and Vendor Representatives 2Health News:Michael and Terry Ward Donate $1 Million to Wounded Warrior Project (WWP) 2Health News:Dr. Web Makes Many Americans Question Trusted Health Providers 2Health News:Dr. Web Makes Many Americans Question Trusted Health Providers 3Health News:ACS Awarded $4 Million Contract to Provide Electronic Patient Records for City of New Orleans EMS 2Health News:DURECT Corporation Invites You to Join Its Second Quarter 2008 Earnings Conference Call 2
Corneal Marking Pen - Sterile. 10 pieces/box...
Replacement PTFE Blocks - 5 centration holes for optimal positioning. 1 piece per box....
... The 4.5/5.0 mm Cannulated Screw ... series of modular systems developed ... screws ranging from 3.5mm to ... and screws, the system was ...
... The 3.5/4.0 mm Cannulated Screw System is ... by DePuy ACE for cannulated screws ranging from ... screw options with necessary instrumentation, the system provides ... the OR staff. The 3.5/4.0 mm system may ...
Medicine Products: